Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
Clement, P. M., Gauler, T., Machiels, J.-P. H., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Cohen, E. E. W., Cupissol, D., Grau, J. J., Guigay, J., Caponigro, F., de Castro, G., de Souza VLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw151
Date:
April, 2016
File:
PDF, 265 KB
english, 2016
File converter
More search results
More benefits 
